What are the most effective real-time markers of kidney cell damage?

Abstract

Real‐time markers for kidney cell damage most consistently report high diagnostic accuracy when measured in the appropriate clinical context and time window. Urinary neutrophil gelatinase‐associated lipocalin (NGAL) rises within 2–6 hours after injury, with studies reporting area under the curve (AUC) values up to 0.91, sensitivities of 84–100%, and specificities as high as 99.5%. Urinary [TIMP‑2]·[IGFBP7] is typically measured at 6–12 hours post‐injury and shows AUC values ranging from 0.70 to 0.94, with reported sensitivities of 42–96% and specificities up to 95%. Urinary kidney injury molecule‑1 (KIM‑1) measured at 12–24 hours post‐insult yields moderate performance (AUC 0.66–0.84) with sensitivities between 75.9% and 91.6% and specificities up to 95.2%.

When combined in multi‐marker panels, these biomarkers often achieve superior performance. For example, panels including NGAL, [TIMP‑2]·[IGFBP7], and cystatin C have produced AUC values as high as 0.98, supporting the use of NGAL, [TIMP‑2]·[IGFBP7], and KIM‑1 as effective real‐time indicators of kidney cell damage.

Methods

We analyzed 40 sources from an initial pool of 999, using 8 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question.

Data extraction

• Study design:

  • Specify the exact type of study design used.
  • Possible types include: Cross-sectional study, Prospective multicenter study, Case-control study, Cohort study.

• Participant characteristics:

  • Total number of participants
  • Patient population
  • Age range or mean age
  • Gender distribution
  • Specific inclusion/exclusion criteria

• Biomarkers investigated:

  • List ALL biomarkers examined in the study for detecting kidney cell damage, including sources and measurement methods.

• Biomarker performance metrics:

  • Extract quantitative performance data for biomarkers, specifically: Area Under the Curve (AUC), Sensitivity, Specificity.

• Primary outcome definition:

  • Describe how acute kidney injury (AKI) was defined and diagnosed in the study.

Results

Characteristics of Included Studies

• Urinary [TIMP-2]·[IGFBP7] showed a range of AUC values from 0.70–0.94 and sensitivities of 42–96%.
• NGAL (urine) had AUC values ranging from 0.62–0.91, with specificities up to 99.5%.
• KIM-1 (urine) exhibited AUC of 0.66–0.84, with sensitivity values between 75.9% and 91.6%.

Summary of Diagnostic Performance

• Area Under the Curve (AUC):
  • 5 biomarkers had minimum AUC values in the poor range (<0.7)
  • 8 biomarkers had AUC values in the fair range (0.7–0.8)
  • 8 biomarkers had AUC values in the good range (0.8–0.9)
  • 5 biomarkers had maximum AUC values in the excellent range (≥0.9)
• Sensitivity:
  • 2 biomarkers had minimum sensitivity values <50%
  • 2 biomarkers had sensitivity values in the 50–69% range
  • 7 biomarkers had sensitivity values in the 70–89% range
  • 5 biomarkers had maximum sensitivity values ≥90%

Combined Biomarker Performance

• Multi-marker panels and combinations reported to outperform single biomarkers, particularly for early detection and risk stratification.

Timing of Detection and Clinical Context

• NGAL (urine): 2–6 hours post-injury; AUC >0.9, Sensitivity 84–100%, Specificity 80–99.5%.
• [TIMP-2]·[IGFBP7]: 6–12 hours post-injury; AUC 0.70–0.94, Sensitivity 89–96%, Specificity 50–95%.
• KIM-1 (urine): 12–24 hours post-injury; AUC 0.66–0.84, Sensitivity 75.9–91.6%, Specificity 61.8–95.2%.

Factors Affecting Biomarker Performance

• The effectiveness of real-time kidney cell damage markers was influenced by clinical context, timing, comorbidities, and methodological factors.